Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1108]

FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET

FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute...

Potential targeted therapy for pediatric brain cancer identified by Dana-Farber team

Potential targeted therapy for pediatric brain cancer identified by Dana-Farber team

Removing a protein ‘signal jammer’ improves immunotherapy

Removing a protein ‘signal jammer’ improves immunotherapy

Promising new therapeutic approach for paediatric brain tumours

Promising new therapeutic approach for paediatric brain tumours

New test identifies high-risk childhood brain tumours, improving treatment decisions

New test identifies high-risk childhood brain tumours, improving treatment decisions

AI-driven advancements in neuroblastoma diagnosis and bone/bone marrow metastasis prediction

AI-driven advancements in neuroblastoma diagnosis and bone/bone marrow metastasis prediction

New genetic testing advances targeted treatments for childhood cancer in the UK

New genetic testing advances targeted treatments for childhood cancer in the UK

Scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma

Scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma

Inherited genetic condition raises risk of developing two rare paediatric cancers

Inherited genetic condition raises risk of developing two rare paediatric cancers

More from ecancer